FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure – MedPage Today

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure  MedPage Today Article Attribution | Read More at Article Source

Shionogi’s COVID antiviral Xocova passes muster with FDA as post-exposure preventative – Fierce Pharma

by News Feed Editor | Jun 1, 2026 | COVID-19

Shionogi’s COVID antiviral Xocova passes muster with FDA as post-exposure preventative  Fierce Pharma Article Attribution | Read More at Article Source

US regulator approves oral drug from Japan’s Shionogi to prevent COVID-19 – Reuters

by News Feed Editor | Jun 1, 2026 | COVID-19

US regulator approves oral drug from Japan’s Shionogi to prevent COVID-19  Reuters Article Attribution | Read More at Article Source

FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19 – Contagion Live

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19  Contagion Live Article Attribution | Read More at Article Source

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 – Drug Topics

by News Feed Editor | Jun 1, 2026 | COVID-19

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19  Drug Topics Article Attribution | Read More at Article Source

(ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure – Business Wire

by News Feed Editor | Jun 1, 2026 | COVID-19

(ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure  Business Wire Article Attribution | Read More at Article Source